Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.  

A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com 

Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com


Primary Logo

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.98
+1.42 (0.68%)
AAPL  274.20
+2.06 (0.76%)
AMD  212.40
-1.44 (-0.67%)
BAC  51.49
+1.09 (2.15%)
GOOG  311.27
+0.35 (0.11%)
META  651.26
+11.96 (1.87%)
MSFT  398.97
+9.97 (2.56%)
NVDA  197.22
+4.37 (2.26%)
ORCL  150.44
+4.30 (2.94%)
TSLA  415.79
+6.41 (1.57%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.